Mitochondria-targeted nanomedicines for cardiovascular applications.
Tabish TA., Lygate CA.
Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.